Enalapril formulations | Patent Number 11040023

US 11040023 B2
Application Number17150587
Publication NumberUS 20210137882 A1
Pendency5 months, 8 days
Filled DateJan 15, 2021
Priority DateMar 18, 2016
Publication DateMay 13, 2021
Expiration DateMar 17, 2036
Inventor/ApplicantsGerold L. Mosher
David W. Miles
ExaminesRAO, SAVITHA M
Art Unit1629
Technology Center1600
Assignments
Jpmorgan Chase Bank
Current
Silvergate Pharmaceuticals Inc.Azurity Pharmaceuticals Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.